Method of treating disorders of the dopaminergic systems using 2,5-diaminotetralines

US5196454A · kind A · utility

Assignee

• Boehringer Ingelheim GmbH · DE

Inventors

• Matthias Grauert · Ingelheim am Rhein, DE
• Herbert Merz · Ingelheim am Rhein, DE
• Joachim Mierau · Mainz, DE
• Gunter Schingnitz · Bad Kreuznach, DE
• Claus Schneider · Ingelheim am Rhein, DE

Key dates

• Filing date: Jun 15, 1990
• Grant date: Mar 23, 1993
• Expiry date: Jun 15, 2010

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2602/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to novel 2,5-diaminotetralines of the formula: ##STR1## wherein R1, R2, R3 and R4 are defined herein, processes for preparing them and their use in pharmaceutical compositions. The novel 2,5-diaminotetralines are useful in treating diseases caused by disorders of the dopaminergic systems.